Minimally invasive diagnostic biomarker strategy successful in detecting early esophageal cancer
New non-invasive method of risk assessment in liver disease
19 May 2022CBT? DBT? Psychodynamic? What type of therapy is right for me?
19 May 2022Minimally invasive diagnostic biomarker strategy successful in detecting early esophageal cancer
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant subtype of esophageal cancer worldwide.
